• Medientyp: E-Artikel
  • Titel: COVID-19 Outcomes in Kidney Transplant Recipients in a German Transplant Center
  • Beteiligte: Mikhailov, Michael; Budde, Klemens; Halleck, Fabian; Eleftheriadis, Georgios; Naik, Marcel G.; Schrezenmeier, Eva; Bachmann, Friederike; Choi, Mira; Duettmann, Wiebke; von Hoerschelmann, Ellen; Koch, Nadine; Liefeldt, Lutz; Lücht, Christian; Straub-Hohenbleicher, Henriette; Waiser, Johannes; Weber, Ulrike; Zukunft, Bianca; Osmanodja, Bilgin
  • Erschienen: MDPI AG, 2023
  • Erschienen in: Journal of Clinical Medicine, 12 (2023) 18, Seite 6103
  • Sprache: Englisch
  • DOI: 10.3390/jcm12186103
  • ISSN: 2077-0383
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Kidney transplant recipients (KTRs) show higher morbidity and mortality from COVID-19 than the general population and have an impaired response to vaccination. We analyzed COVID-19 incidence and clinical outcomes in a single-center cohort of approximately 2500 KTRs. Between 1 February 2020 and 1 July 2022, 578 KTRs were infected with SARS-CoV-2, with 25 (4%) recurrent infections. In total, 208 KTRs (36%) were hospitalized, and 39 (7%) died. Among vaccinated patients, infection with the Omicron variant had a mortality of 2%. Unvaccinated patients infected with the Omicron variant showed mortality (9% vs. 11%) and morbidity (hospitalization 52% vs. 54%, ICU admission 12% vs. 18%) comparable to the pre-Omicron era. Multivariable analysis revealed that being unvaccinated (OR = 2.15, 95% CI [1.38, 3.35]), infection in the pre-Omicron era (OR = 3.06, 95% CI [1.92, 4.87]), and higher patient age (OR = 1.04, 95% CI [1.03, 1.06]) are independent risk factors for COVID-19 hospitalization, whereas a steroid-free immunosuppressive regimen was found to reduce the risk of COVID-19 hospitalization (OR = 0.51, 95% CI [0.33, 0.79]). This suggests that both virological changes in the Omicron variant and vaccination reduce the risk for morbidity and mortality from COVID-19 in KTRs. Our data extend the knowledge from the general population to KTRs and provide important insights into outcomes during the Omicron era.
  • Zugangsstatus: Freier Zugang